1Gerald LM,John EB, Raphael D. et al. Principles and practice of infectious diseases[M]. 2005.5 : 2310-2335.
2Hancock RE.Brinkman FS. Function of pseudomonas porins in uptake and efflux[J]. Annu Rev Microbiol, 2002.56: 17-38.
3Pirnay JP, De Vos D, Mossialos D. et al. Analysis of the Pseudomonas aeruginosa oprD gene from clinical and environmental iso lates[J]. Environ Microbiol, 2002,4 (12) : 872-882.
4Zgurskaya HI; Nikaido H. Multidrug resistance mechanisms: drug efflux across two membranes[J]. Mol Microbiol, 2000, 37(2) :219-225.
6Dumas JL,van Delden C,Perron K,et al. Analysis of antibiotic resistance gene expression in Pseudomonas aeruginosa by quantitative real-time-PCR[J]. FEMS Microbiol Lett, 2006, 254(2) :217-225.
7Nouwens AS.Willcox MD,Walsh BJ, et al. Proteomie comparison of membrane and extracellular proteins from invasive ( PAO1 ) and eytotoxic (6206) strains of Pseudomonas aeruginosa[J]. Proteomics,2002,2(9) : 1325-1346.
8Osano E, Arakawa Y,Wacharotayankun R. et al. Molecular characterization of an enterobacterial metallo beta-lactamase found in a clinical isolate of Serratia marcescens that shows imipenem resistance [J]. Antimicrob Agents Chemother. 1994,38(1 ) :71-78.
9Ricclo ML, Franceschini N, Boschi L, et al. Characterization of the metallo-b-lactamase determinant of Aeinetobacter baumannii AC-54/97 reveals the existence of bla(IMP) allelic variants carried by gene cassettes of different phylogeny[J]. Antimicrob Agents Chemother, 2000,44(5) : 1229-1235.
10Iyobe S, Kusadokoro H, Ozaki J, et al. Amino acid substitutions in a variant of IMP-1 metallo-b-lactamase[J]. Antimicrob Agents Chemother,2000,44(8) :2023-2027.
